B of A Securities Maintains Underperform on Moderna, Raises Price Target to $38

Benzinga · 07/07 14:23
B of A Securities analyst Dimple Gosai maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $34 to $38.